| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
Fresh off closing a $650 million fund to invest in information technology and life sciences companies, InterWest Partners LLC has booked two more deals in, yep, IT and life sciences. InterWest is one of the most active--and interesting--early-stage venture capital investors around these days. In the first of its two latest investments, the firm joined Storm Ventures in putting $8 million in a Series B round in Marketo Inc., which provides marketing automation software. In the other deal, InterWest joined in an $11 million Series B funding led by Polaris Venture Partners for Follica Inc., which makes therapies for treating baldness and related hair loss disorders (count me in). The timing of these deals is not coincidental. With the economy sagging, InterWest wants "to make sure companies make it through what we expect to be a tumultuous financial period," partner Bruce Cleveland told us earlier this year. -- Alain Sherter Other recent InterWest fundings: • AMEC, wafer fabrication • Brite Semiconductor, chip design • CVRx, medical devices • Gear6, storage • Invisage Technologies Inc., materials • NexPlanar Corp., semiconductor manufacturing • Ocera Therapeutics Inc., biopharmaceutical • Pivot3 Inc., storage • Quantance, power management • SignalDemand Inc., pricing software See Aug. 11 post on InterWest's new fund from Tech Confidential See Aug. 12 press release on its latest investment round from Marketo See Aug. 12 press release on its latest investment round from Follica See April 14 post on InterWest's funding strategy from Tech Confidential
 Deal Video
    Community
 Elsewhere on The Deal.comDealwatchThe Deal MagazineCorporate Dealmaker
The Deal VideoCategories
Blog roll
Archives
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
